Oxidative stress in rat hippocampus caused by pilocarpine-induced seizures is reversed by buspirone

Brain Research Bulletin

Volumn 81, Issue 4-5, 2010, Pages 505-509

  de Freitas, Rizângela Lyne Mendes ^a   Santos, Ítala Mônica de Sales ^b   de Souza, Geane Felix ^c   Tomé, Adriana da Rocha ^d   Saldanha, Gláucio Barros ^a   de Freitas, Rivelilson Mendes ^b  

^a Catholic Faculty Rainha do Sertão ^*  (Brazil)

^b FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^c Clinical Pathology Laboratory   (Brazil)

^d STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Buspirone; Hippocampus; Lipid peroxidation; Nitrite; Oxidative stress; Seizures

Indexed keywords

BUSPIRONE; CATALASE; NITRITE; PILOCARPINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; EPILEPTIC STATE; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; BUSPIRONE; CATALASE; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NITRITES; OXIDATIVE STRESS; PILOCARPINE; RATS; RATS, WISTAR; SEIZURES; SEROTONIN AGONISTS; STATUS EPILEPTICUS; SUPEROXIDE DISMUTASE; TIME FACTORS;

EID: 74449089119     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.09.014     Document Type: Article

References (42)

1. Bergamini C.M., Gambetti S., Dondi A., and Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr. Pharm. Des. 10 (2004) 1611-1626
2. Caccia S., Conti I., Vigano G., and Garattini S. 1-(2-Pyrimidinyl)-piperazine as active metabolite of buspirone in man and rat. Pharmacology 33 (1986) 46-51
3. Chance B., and Maehly A.C. Assay of catalases and peroxidases. Methods Enzymol. 2 (1955) 764-768
4. Comim C.M., Cassol Jr. O.J., Constantino L.C., Constantino L.S., Petronilho F., Tuon L., VainzoF M., Dal-Pizzol F., and Quevedo J. Oxidative variables and antioxidant enzymes activities in the mdx mouse brain. Neurochem. Int. (2009) (Epub ahead of print)
5. Draper H.H., and Hadley M. Malondialdehyde determination as an index of lipid peroxidation. Methods Enzymol. 186 (1990) 421-431
6. Dymond A.M., and Crandall P.H. Oxygen availability and blood flow in the temporal lobes during spontaneous epileptic seizures in men. Brain Res. 102 (1976) 191-196
7. Flohe L., and Otting F. Superoxide dismutase assays. Methods Enzymol. 105 (1984) 93-104
8. Freitas R.L., Ferreira C.M., Ribeiro S.J., Carvalho A.D., Elias-Filho D.H., Garcia-Cairasco N., and Coimbra N.C. Intrinsic neural circuits between dorsal midbrain neurons that control fearinduced responses and seizure activity and nuclei of the pain inhibitory system elaborating postictal antinociceptive processes: a functional neuroanatomical and neuropharmacological study. Exp. Neurol. 191 (2005) 225-242
9. Freitas R.M., Souza F.C.F., Vasconcelos S.M.M., Viana G.S.B., and Fonteles M.M.F. Pilocarpine-induced status epilepticus in rats: lipid peroxidation level, nitrite formation, GABAergic and glutamatergic receptor alterations in the hippocampus, striatum and frontal cortex. Pharmacol. Biochem. Behav. 78 (2004) 327-332
10. Freitas R.M., Souza F.C.F., Vasconcelos S.M.M., Viana G.S.B., and Fonteles M.M.F. Oxidative stress in the hippocampus after status epilepticus in rats. FEBS J. 272 (2005) 1307-1312
11. Gaspar P., Cases O., and Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4 (2003) 1002-1012
12. Green L.C., Tannenbaum S.R., and Goldman P. Nitrate synthesis in the germfree and conventional rat. Science 212 (1981) 56-58
13. Halliwell B., and Gutteridge J.M.C. Free Radicals in Biology and Medicine (1999), Oxford Science Publications, London
14. Halliwell B., and Gutteridge J.M.C. Lipid Peroxidation: A Radical Chain Reaction (Free Rad. Biol. Med.) (1989), Clarendon Press, Oxford pp. 188-276
15. Hoyer D., and Boddeke H.W. Partial agonists, full agonists, antagonists: dilemmas of definition. Trends Pharmacol. Sci. 14 (1993) 270-275
16. Inden M., Kitamura Y., Tamaki A., Yanagida T., Shibaike T., Yamamoto A., Takata K., Yasui H., Taira T., Ariga H., and Taniguchi T. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice. Neurochem. Int. (2009) (Epub ahead of print)
17. Kääriäinen T.M., Lehtonen M., Forsberg M.M., Savolainen J., Käenmäki M., and Männistö P.T. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats. Basic Clin. Pharmacol. Toxicol. 102 (2008) 50-58
18. Kelly J.P., Wrynn A.S., and Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 74 (1997) 299-316
19. Kennett G.A., Marcou M., Dourish C.T., and Curzon G. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaotic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 138 (1987) 53-60
20. Kennett G.A., Dourish C.T., and Curzon G. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur. J. Pharmacol. 134 (1987) 265-274
21. Kroll W., and Gassmayr S.E. Pre-operative anxiety, stress and pre-medication. Baillière's Clin. Anaesthesiol. 12 (1998) 485-495
22. 2-like dopaminergic receptor density in rat striatum. Arq. Neuropsiquiatr. 60 (2002) 38-40
23. Lowry H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurements with the folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
24. Lucki I., Singh A., and Kreiss D.S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci. Biobehav. Rev. 18 (1994) 85-95
25. Lumia A.R., Teicher M.H., Salchli F., Ayers E., and Possidente B. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 587 (1992) 181-185
26. Maehly A.C., and Chance B. The assay of catalases and peroxidases. Methods Biochem. Anal. 1 (1954) 357-359
27. Militão G.C.G., Ferreira P.M.P., and Freitas R.M. Effects of lipoic acid on oxidative stress in rat striatum after pilocarpine-induced seizures. Neurochem. Int. (2009) [E-pub ahead of print]
28. Nishi K., Kanemaru K., Hasegawa S., Watanabe A., and Diksic M. Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats. Neurochem. Int. 54 (2009) 205-214
29. Ohlsen R.I., and Pilowsky L.S. The place of partial agonism in psychiatry: recent developments. J. Psychopharmacol. 19 4 (2005) 408-413
30. Peroutka S.J. 5-Hydroxytryptamine receptor subtypes. Ann. Rev. Neurosci. 7 (1988) 45-48
31. Ramiro-Cortés Y., and Morán J. Role of oxidative stress and JNK pathway in apoptotic death induced by potassium deprivation and staurosporine in cerebellar granule neurons. Neurochem. Int. 55 (2009) 581-592
32. Riegel R.E., Valvassori S.S., Elias G., Réus G.Z., Steckert A.V., de Souza B., Petronilho F., Gavioli E.C., Dal-Pizzol F., and Quevedo J. Animal model of mania induced by ouabain: evidence of oxidative stress in submitochondrial particles of the rat brain. Neurochem. Int. 55 (2009) 491-495
33. Rosa-Neto P., Diksic M., Okazawa H., Leyton M., Ghadirian N., Mzengeza S., Nakai A., Debonnel G., Blier P., and Benkelfat C. Measurement of brain regional alpha-[11C]methyl-ltryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch. Gen. Psychiatry 61 (2004) 556-563
34. Sato H., Skelin I., Debonnel G., and Diksic M. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: Assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites. Brain Res. Bull. 75 (2008) 545-555
35. Skelin I., Yamane F., and Diksic M. Flesinoxan challenge suggests that chronic treatment with paroxetine in rats does not desensitize receptors controlling 5-HT synthesis. Neurochem. Int. 53 (2008) 236-243
36. Spoont M.R. Modulatory role of serotonin in neural information processing: implications for human psychopathology. Psychol. Bull. 112 (1992) 330-350
37. Tejada S., Roca C., Sureda A., Rial R.V., Gamundí A., and Esteban S. Antioxidant response analysis in the brain after pilocarpine treatments. Brain Res. Bull. 69 (2006) 587-592
38. Tohyama Y., Yamane F., Fikre-Merid M., Blier P., and Diksic M. Effects of serotonin receptor agonists, TFMP and CGS12066B, on regional serotonin synthesis in the rat brain: an autoradiographic study. J. Neurochem. 80 (2008) 788-798
39. Turski W.A., Cavalheiro E.A., Schwartz M., Czuczwar S.J., Kleinrok Z., and Turski L. Limbic seizures produced by pilocarpine in rats: a behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 9 (1983) 315-335
40. De Vivo M., and Maayani S. Characterization of the 5-hydroxytryptamine1A receptor-mediated inhibition of Forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmacol. Exp. Ther. 238 (1986) 248-253
41. Watanabe A., Tohyama Y., Nguyen K.Q., Hasegawa S., Debonnel G., and Diksic M. Regional brain serotonin synthesis is increased in the olfactory bulbectomy rat model of depression: an autoradiographic study. J. Neurochem. 85 (2003) 469-475
42. Ziai W.C., Sherman D.L., Bhardwaj A., Zhang N., Keyl P.M., and Mirski M.A. Target-specific catecholamine elevation induced by anticonvulsant thalamic deep brain stimulation. Epilepsia 46 (2005) 878-888